Clicky

AbbVie Inc(4AB) News

Date Title
Aug 25 Is There An Opportunity With AbbVie Inc.'s (NYSE:ABBV) 42% Undervaluation?
Aug 24 Top Analyst Reports for Procter & Gamble, AbbVie & Walt Disney
Aug 24 CVS Health launches new brand Cordavis to target $100 billion biosimilar market
Aug 24 Can AbbVie (ABBV) Protect Revenues After Humira Patent Loss?
Aug 24 CVS is launching a genius way to cut costs for its customers
Aug 23 UPDATE 2-CVS launches unit to market and co-produce biosimilar medicines
Aug 22 12 Best Cheap Dividend Stocks To Buy Now
Aug 22 7 Top Dividend Stocks for Income and Stability
Aug 21 These 3 Large-Cap Pharma Stocks Have Been Red-Hot
Jul 19 AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know
Jul 18 12 Best Dividend Stocks Under $25
Jul 18 The Zacks Analyst Blog Highlights Walmart, AbbVie, Nike, Uber and PayPal
Jul 17 Top Analyst Reports for Walmart, AbbVie & Nike
Jul 17 12 Best Dividend Stocks Under $10
Jul 17 AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Jul 16 3 Dividend Growth Stocks to Buy and Hold
Jul 16 7 Spectacular High-Yield Dividend Stocks to Buy in July
Jul 13 AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Jul 13 Big Pharma Ramps Up Fight Against Medicare Price Negotiations
Jul 13 AbbVie (NYSE:ABBV) shareholders have earned a 14% CAGR over the last five years